Search
for
Sort by
Research 30 of 1000+
- Hair loss and Hedgehog inhibitors: a class effect?
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- From basal cell carcinoma morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- 139 Anti-BCC efficacy of a topical hedgehog inhibitor without adverse effects in BCNS patients in a phase 2 randomized controlled trial
- Suppression of hair follicle development inhibits induction of sonic hedgehog, patched, and patched-2 in hair germs in mice
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
- AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma
- Roles of the Hedgehog Signaling Pathway in Cutaneous Physiology and Oncology
- Author response: Coordinated hedgehog signaling induces new hair follicles in adult skin
- WISP-1 induced by mechanical stress contributes to fibrosis and hypertrophy of the ligamentum flavum through Hedgehog-Gli1 signaling
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
- Data from Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- 085 Dermal papilla cells control hair follicle matrix keratinocytes proliferation through versican
- Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma
- Management of Dermatologic Toxicities
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Drug-induced scarring and permanent alopecia
- Non-surgical treatments for basal cell skin cancer
- Aberrant Wnt Signaling Induces Comedo-Like Changes in the Murine Upper Hair Follicle